Evidence map›Paper›PMID 36561910›Full record

ArticlePublic health action2022

Facilitators and barriers to TB care during the COVID-19 pandemic.

M A Franke, L M Truß, H Wierenga, K Nordmann, A Frühauf, R Ranaivoson, Z Rampanjato, F Ranjaharinony, S Knauss, N Muller and 1 more

Abstract read
In one paragraph

Article in Public health action, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

M A FrankeCharité Global Health, Charité - Universitätsmedizin, Berlin, Germany.
L M TrußCharité Global Health, Charité - Universitätsmedizin, Berlin, Germany.
H WierengaDoctors for Madagascar, Antananarivo, Madagascar.
K NordmannCharité Global Health, Charité - Universitätsmedizin, Berlin, Germany.
A FrühaufCharité Global Health, Charité - Universitätsmedizin, Berlin, Germany.
R RanaivosonDoctors for Madagascar, Antananarivo, Madagascar.
Z RampanjatoDoctors for Madagascar, Antananarivo, Madagascar.
F RanjaharinonyDoctors for Madagascar, Antananarivo, Madagascar.
S KnaussCharité Global Health, Charité - Universitätsmedizin, Berlin, Germany.
N MullerCharité Global Health, Charité - Universitätsmedizin, Berlin, Germany.
J V EmmrichCharité Global Health, Charité - Universitätsmedizin, Berlin, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundKnowledge about factors influencing access and adherence to TB care, and on the impact of the COVID-19 pandemic on TB care in resource-restricted settings is scarce. We conducted this study in Atsimo-Andrefana, a rural region in southern Madagascar where TB prevalence, poverty and food insecurity rates are high. We aimed to determine facilitators and barriers to access to and provision of TB care in rural Madagascar during the COVID-19 pandemic.

methodsWe conducted qualitative focus group discussions (FGDs) and in-depth interviews (IDIs) with patients with TB, community health workers, facility-based health workers, public health officials and non-governmental organisation staff. We analysed interviews using thematic analysis.

resultsWe conducted 11 FGDs and 23 IDIs. We identified three main barriers to access and adherence to TB care: 1) stigma, 2) indirect treatment costs, and 3) food insecurity. The facilitator perceived as most influential was high health worker motivation. The effects of the COVID-19 pandemic on TB care varied between stake-holders; some health workers described delays in TB diagnosis and increased workload.

conclusionsTo improve access and adherence to TB care, both indirect treatment costs and stigma need to be reduced; undernourished patients with TB should receive food support.

Indexed as

respiratory diseaseSars-CoV-2sub-Saharan Africa

Identifiers

PMID36561910
PMCPMC9716826

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.